Related Experiment Video
Updated: Jan 3, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.8K
Principles of Immunotherapy in Melanoma
Adedayo A Onitilo1, Jaimie A Wittig2
1Department of Hematology/Oncology, Marshfield Clinic - Weston Center, 3501 Cranberry Boulevard, Weston, WI 54476, USA.
The Surgical Clinics of North America
|November 23, 2019
Summary
Immunotherapies offer improved outcomes for advanced melanoma by leveraging the immune system, unlike traditional chemotherapy. Close monitoring and modified response criteria are crucial for managing side effects and tracking treatment effectiveness.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Advanced/metastatic melanoma presents a significant challenge due to its aggressive nature and low survival rates.
- Conventional treatments like cytotoxic chemotherapy offer limited efficacy and systemic cytokine/chemokine therapies cause adverse effects.
- Immunotherapies harness the immune system's capabilities for cancer surveillance and destruction, offering durable responses.
Purpose of the Study:
- To highlight the benefits of immunotherapy for advanced/metastatic melanoma.
- To emphasize the need for vigilant monitoring of immune-related adverse events.
- To introduce modified response criteria for assessing treatment efficacy in metastatic melanoma.
Main Methods:
- Review of current understanding of immunotherapy in advanced melanoma.
- Discussion of immune-related adverse events and their management.
- Explanation of modified response criteria for evaluating treatment response.
Main Results:
- Immunotherapy demonstrates improved disease outcomes and durable responses in advanced/metastatic melanoma.
- Early identification and management of immune-related adverse events are critical for patient safety.
- Modified response criteria aid in tracking differential responses of metastatic lesions to immunotherapy.
Conclusions:
- Immunotherapy represents a promising approach for advanced/metastatic melanoma, improving patient outcomes.
- Close patient monitoring and adaptive response assessment are essential components of successful immunotherapy treatment.
- Further research and refinement of response evaluation tools are necessary to optimize immunotherapy application.
Related Concept Videos
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:30Cancer Vaccines
907
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
907
01:27Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
01:30Skin Cancer
5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K